Meta-analysis application to hERG safety evaluation in clinical trials.

Area of Science:

• Pharmacology
• Clinical Pharmacology
• Biostatistics

Background:

• Meta-analysis synthesizes evidence to assess study consistency and heterogeneity.
• Moxifloxacin is a positive control in QT assessment studies.
• Characterizing drug effects on QT intervals is crucial for cardiac safety evaluation.

Purpose of the Study:

• To perform a meta-analysis on moxifloxacin data from 26 thorough QT studies.
• To characterize the exposure-response relationship and determine the safety margin for a 10-msec QTc effect.
• To estimate the critical concentration of moxifloxacin associated with this effect.

Main Methods:

• Utilized multiple meta-analysis methods, including novel approaches.
• Compared aggregate data versus individual participant data and fixed-effect versus random-effect models.
• Applied concentration-QTc models to estimate critical concentrations and confidence intervals.

Main Results:

• Demonstrated both homogeneity and heterogeneity in the moxifloxacin concentration-QTc relationship across studies.
• Estimated the critical concentration of moxifloxacin associated with a 10-msec QTc effect.
• Provided data for calculating the hERG safety margin of moxifloxacin.

Conclusions:

• The meta-analysis successfully characterized the moxifloxacin exposure-response relationship.
• The estimated critical concentration is valuable for assessing cardiac safety margins.
• This work contributes to understanding drug-induced QT interval prolongation and safety assessment.